Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Menzer, C; Beedgen, B; Rom, J; Duffert, CM; Volckmar, AL; Sedlaczek, O; Richtig, E; Enk, A; Jäger, D; Hassel, JC.
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy.
Eur J Cancer. 2018; 104(2):239-242
Doi: 10.1016/j.ejca.2018.09.008
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Richtig Erika
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Cesarean Section -
-
Digestive System Neoplasms - drug therapy
-
Digestive System Neoplasms - secondary
-
Fatal Outcome -
-
Female -
-
Humans -
-
Immunotherapy - methods
-
Infant, Newborn -
-
Infant, Premature -
-
Ipilimumab - administration & dosage
-
Lymphatic Metastasis -
-
Maternal-Fetal Exchange -
-
Melanoma - drug therapy
-
Melanoma - secondary
-
Neoplasm Micrometastasis -
-
Nevus, Epithelioid and Spindle Cell -
-
Nivolumab - administration & dosage
-
Placenta - pathology
-
Pregnancy -
-
Pregnancy Complications, Neoplastic - drug therapy
-
Pregnancy Trimester, Second -
-
Respiratory Tract Neoplasms - drug therapy
-
Respiratory Tract Neoplasms - secondary
-
Skin Neoplasms - drug therapy
-
Skin Neoplasms - secondary
-
Spinal Neoplasms - drug therapy
-
Spinal Neoplasms - secondary